Drugs Made In America Acquisition (DMII) Assets Average (2025)
Drugs Made In America Acquisition (DMII) reported Assets Average of $503.0 million for Q4 2025, up 100.73% on a QoQ basis from $250.6 million in Q3 2025.
Drugs Made In America Acquisition (DMII) has 1 years of Assets Average data on file, last reported at $503.0 million in Q4 2025.
- Quarterly Assets Average changed N/A year-over-year to $503.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $503.0 million (changed N/A YoY) and the FY2025 annual result came in at $252.5 million, changed N/A from the prior year.
- Assets Average climbed to $503.0 million in Q4 2025 per DMII's latest filing, from $250.6 million in the prior quarter.
- Across five years, Assets Average topped out at $503.0 million in Q4 2025 and bottomed at $250.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 472.34 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 310.58 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 309.64 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 309.16 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 372.24 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 287.89 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 271.71 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 285.27 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 261.34 Mn |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | 502.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 502.98 Mn |
| Sep 30, 2025 | 250.57 Mn |